US Stock In Play: $PRTA
PRTA late stage biotech firm. have higher low tightening price action since mid dec, closing above 10/20 and 200MA for the first time after a ATH peak to trough correction of -38% 3 months ago. lucrative risk reward if this trades work
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.